Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2441109
Max Phase: Preclinical
Molecular Formula: C20H17NO4
Molecular Weight: 335.36
Molecule Type: Small molecule
Associated Items:
ID: ALA2441109
Max Phase: Preclinical
Molecular Formula: C20H17NO4
Molecular Weight: 335.36
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccccc1C(=O)Nc1ccc(Oc2ccc(O)cc2)cc1
Standard InChI: InChI=1S/C20H17NO4/c1-24-19-5-3-2-4-18(19)20(23)21-14-6-10-16(11-7-14)25-17-12-8-15(22)9-13-17/h2-13,22H,1H3,(H,21,23)
Standard InChI Key: YGLHYBQSRDRNOB-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 335.36 | Molecular Weight (Monoisotopic): 335.1158 | AlogP: 4.45 | #Rotatable Bonds: 5 |
Polar Surface Area: 67.79 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.70 | CX Basic pKa: | CX LogP: 4.10 | CX LogD: 4.10 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.72 | Np Likeness Score: -0.79 |
1. Yamada A, Fujii S, Mori S, Kagechika H.. (2013) Design and Synthesis of 4-(4-Benzoylaminophenoxy)phenol Derivatives As Androgen Receptor Antagonists., 4 (10): [PMID:24900588] [10.1021/ml4001744] |
Source(1):